Search research articles
Contact Us
Filters
Showing results (261-270 of 444) with videos related to
Page
of 45
Sort By:
Journal of Neurosurgery
|
January 14, 2015
Response
Gelareh Zadeh, Sameer Agnihotri, Isabel Gugel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 10, 2008
Lower osteopontin plasma levels are associated with superior outcomes in advanced non-small-cell lung cancer patients receiving platinum-based chemotherapy: SWOG Study S0003
Philip C Mack, Mary W Redman, Kari Chansky, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 1, 2007
Sorafenib with interferon alfa-2b as first-line treatment of advanced renal carcinoma: a phase II study of the Southwest Oncology Group
Christopher W Ryan, Bryan H Goldman, Primo N Lara, et al.
Cancer Research
|
December 1, 1995
Yttrium-90 chimeric L6 therapy of human breast cancer in nude mice and apoptosis-related messenger RNA expression
S J DeNardo, P H Gumerlock, M D Winthrop, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
September 2, 2008
Southwest Oncology Group phase II trial (S0341) of erlotinib (OSI-774) in patients with advanced non-small cell lung cancer and a performance status of 2
Paul J Hesketh, Kari Chansky, Antoinette J Wozniak, et al.
Cancer
|
April 23, 2014
A phase 2 cooperative group adjuvant trial using a biomarker-based decision algorithm in patients with stage I non-small cell lung cancer (SWOG-0720, NCT00792701)
Gerold Bepler, Ralph G Zinner, James Moon, et al.
Clinical Lung Cancer
|
November 10, 2021
EGFR High Copy Number Together With High EGFR Protein Expression Predicts Improved Outcome for Cetuximab-based Therapy in Squamous Cell Lung Cancer: Analysis From SWOG S0819, a Phase III Trial of Chemotherapy With or Without Cetuximab in Advanced NSCLC
Fred R Hirsch, Mary W Redman, James Moon, et al.
Cancer Letters
|
April 24, 2007
Origin and prognostic value of circulating KRAS mutations in lung cancer patients
O Gautschi, B Huegli, A Ziegler, et al.
Journal of Clinical and Experimental Neuropsychology
|
June 11, 2009
Persistent neuropsychological impairment associated with West Nile virus infection
Joseph R Sadek, Steven A Pergam, Jennifer A Harrington, et al.
Nature
|
July 22, 2014
A shift of thermokarst lakes from carbon sources to sinks during the Holocene epoch
K M Walter Anthony, S A Zimov, G Grosse, et al.
Page
of 45
Search research articles
Search
Showing results (261-270 of 444) with videos related to
Sort By:
Page
of 45
Journal of Neurosurgery
|
January 14, 2015
Response
Gelareh Zadeh, Sameer Agnihotri, Isabel Gugel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 10, 2008
Lower osteopontin plasma levels are associated with superior outcomes in advanced non-small-cell lung cancer patients receiving platinum-based chemotherapy: SWOG Study S0003
Philip C Mack, Mary W Redman, Kari Chansky, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 1, 2007
Sorafenib with interferon alfa-2b as first-line treatment of advanced renal carcinoma: a phase II study of the Southwest Oncology Group
Christopher W Ryan, Bryan H Goldman, Primo N Lara, et al.
Cancer Research
|
December 1, 1995
Yttrium-90 chimeric L6 therapy of human breast cancer in nude mice and apoptosis-related messenger RNA expression
S J DeNardo, P H Gumerlock, M D Winthrop, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
September 2, 2008
Southwest Oncology Group phase II trial (S0341) of erlotinib (OSI-774) in patients with advanced non-small cell lung cancer and a performance status of 2
Paul J Hesketh, Kari Chansky, Antoinette J Wozniak, et al.
Cancer
|
April 23, 2014
A phase 2 cooperative group adjuvant trial using a biomarker-based decision algorithm in patients with stage I non-small cell lung cancer (SWOG-0720, NCT00792701)
Gerold Bepler, Ralph G Zinner, James Moon, et al.
Clinical Lung Cancer
|
November 10, 2021
EGFR High Copy Number Together With High EGFR Protein Expression Predicts Improved Outcome for Cetuximab-based Therapy in Squamous Cell Lung Cancer: Analysis From SWOG S0819, a Phase III Trial of Chemotherapy With or Without Cetuximab in Advanced NSCLC
Fred R Hirsch, Mary W Redman, James Moon, et al.
Cancer Letters
|
April 24, 2007
Origin and prognostic value of circulating KRAS mutations in lung cancer patients
O Gautschi, B Huegli, A Ziegler, et al.
Journal of Clinical and Experimental Neuropsychology
|
June 11, 2009
Persistent neuropsychological impairment associated with West Nile virus infection
Joseph R Sadek, Steven A Pergam, Jennifer A Harrington, et al.
Nature
|
July 22, 2014
A shift of thermokarst lakes from carbon sources to sinks during the Holocene epoch
K M Walter Anthony, S A Zimov, G Grosse, et al.
Page
of 45